"A more accurate mammogram: Genius™"*

Breast Cancer Survivor

The Genius™ exam should be your #1 choice for cancer detection – especially if you have dense breasts.4-5*

Enter your email and zip code and we’ll send you a list of Genius™ 3D™ exam facilities near you.

HyperFocal: 0

Did you know?

  • 1 in every 8 women you know will likely develop breast cancer1
  • The risk of cancer increases in those with dense breasts
  • 1 in 2 women over age 40 has dense breasts2-3

But, if caught early, the 5-year survival rate is almost 100%.8

Get a list of Genius™ exam facilities near you and ask your doctor about breast density today.


Why the Genius™ exam?

Only the Genius™ 3D Mammography™ exam:

  • Is approved by the FDA as a superior mammogram for women with dense breasts.4-5*
  • Detects 20-65% more invasive breast cancers, compared to 2D mammography alone.6
  • With the SmartCurve™ system9, reduces the amount of discomfort you feel during your mammogram.10

The Genius™ exam should be your first step when it comes to breast cancer screening.

Visit MyGenius3D.com

* Compared to 2D mammography alone.

  1. Breastcancer.org. US breast cancer statistics. Breastcancer.org. http://www.breastcancer.org/symptoms/understand_bc/statistics. Accessed on: May 25, 2016

  2. Ho JM, Jafferjee N, Covarrubias GM, Ghesani M, Handler B. Dense breasts: a review of reporting legislation and available supplemental screening options. AJR Am J Roentgenol. 203(2):449-56, 2014.

  3. Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. 106(10), 2014.

  4. FDA submissions P080003, P080003/S001, P080003/S004, P080003/S005

  5. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507.

  6. Results from Friedewald, SM, et al. "Breast cancer screening using tomosynthesis in combination with digital mammography." JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia Dimensions on screening outcomes. Individual results may vary. The study found an average 41% increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3D(TM) mammograms acquired with the Hologic 3D Mammography(TM) System versus women receiving 2D FFDM mammograms only.

  7. Bernardi D, Macaskill P, Pellegrini M, et al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.

  8. National Breast Cancer Foundation, Inc. Stages 0 & 1: what does is mean to have stage 1 breast cancer? National Breast Cancer Foundation, Inc. http://www.nationalbreastcancer.org/breast-cancer-stage-0- and-1. Accessed on: March 31, 2015

  9. Not available at all facilities. Please contact your healthcare professional for more information.

  10. Smith, A. Improving Patient Comfort in Mammography. Hologic WP-00019 Rev 003(2017)